Mauna Kea Technologies
  • Physicians
    • Overview
    • Cellvizio system
    • Education
    • Reimbursement
    • GastroEnterology
    • Barrett’s Esophagus
    • Pancreatic Cysts
    • Gastric Disease
    • Inflammatory Bowel Diseases
    • Irritable Bowel Syndrome
    • Bilio-Pancreatic Strictures
    • Colorectal Lesions
    • Pulmonology
    • Lung Nodules
    • Covid-19
    • Urology
  • Investors
  • About us
    • Our story
    • Team
    • Board of Directors
    • Leadership
    • Join Us
    • Commercial Network
  • News & events
  • US
  • INT
  • FR
Contact

News & Events

Lung news and event.png
NEWS - Cellvizio
Jul 26, 2022

On Target Laboratories and Mauna Kea Technologies Further Explore Targeted Detection and Real-Time Diagnosis of Lung Cancer with a Molecular Imaging Agent

Discover
MKT Card.png
NEWS - Cellvizio
Jul 21, 2022

Mauna Kea Technologies Announces Q2 and 1H 2022 Revenues

Discover
MKT Card.png
EVENTS - Cellvizio
Jul 12, 2022

Webinar: Tasly Pharmaceuticals and Mauna Kea Technologies Joint Venture

Discover
MKT Card.png
NEWS - Cellvizio
Jul 11, 2022

Tasly Pharmaceuticals and Mauna Kea Technologies Announce Joint Venture and Licensing Agreements

Discover
BE news and event.png
NEWS - Cellvizio
Jul 6, 2022

Mauna Kea Technologies Announces Publication of a Meta-Analysis Demonstrating Cellvizio’s Significant Role in Detection of Esophageal Dysplasia and Cancer

Discover
Lung news and event.png
NEWS - Cellvizio
May 18, 2022

On Target Laboratories and Mauna Kea Technologies Demonstrate Intraprocedural Targeted Detection of Lung Cancer with a Molecular Imaging Agent

Discover
See more
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
  • Legal notice
  • Join Us
  • Contact us
  • Cellvizio.net
  • DiagnosingBarretts.org
  • DiagnosingPancreaticCysts.org
Mauna Kea Technologies